USA TODAY |
5 things we learned from EpiPen price hike hearing
USA TODAY That's generally accurate for 2015, according to a recent USA TODAY review of S&P Global Market Intelligence data. But for the last five years, Mylan had the second-highest executive compensation in the entire drug industry, according to the Wall ... |
